Shanghai, China, 07 July, 2025 - MicroPort® MedBot™ is excited to share that its Toumai® Endoscopic Surgical Robot (Toumai®) has been honored with “Groundbreaking Technology” award at the Surgical Robotics Industry Awards 2025, a key global recognition for excellence in surgical robotics innovation. This recognition underscores Toumai®’s technological innovation and clinical excellence.
Hosted by Surgical Robotics Technology (SRT), a globally recognized media platform dedicated to surgical robotics, the award highlights industry leaders advancing the future of surgical care.
To date, Toumai® has been approved in more than 30 countries and regions worldwide and continues to lead the way in remote surgery innovation. In April this year, it became the first surgical robot globally to receive multi-specialty regulatory approval for remote surgery applications, a milestone in the evolution of tele-surgical care.
Dr. Alex He, President of MicroPort® MedBot™, commented: “We strive to connect lives through technology, reshape equity through innovation, and work hand in hand with global partners to build a smarter, more accessible, and more equitable surgical robotics ecosystem.”
About MicroPort® MedBot™
Commenced its development for laparoscopic surgery robots in 2014, and officially established in Shanghai in 2015, Shanghai MicroPort MedBot (Group) Co., Ltd. ("MicroPort® MedBot™", stock code: 02252.HK), a subsidiary of MicroPort Scientific Corporation ("MicroPort®", stock code: 00853.HK), is currently the only surgical robot company in the world with businesses covering five promising subsectors of surgical robots, including endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture. At MicroPort® MedBot™, we are committed to meeting the growing demand for cutting-edge robotic surgery. By integrating advanced research on robotics, control algorithms, image-based navigation, and precision imaging, we provide comprehensive intelligent surgical solutions to prolong and reshape the lives of patients, lead the advancement of robotic surgery, and shape the era of intelligent surgery.
More information is available at: www.medbotsurgical.com/en